Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsOrthopaedic Oncology & Bone TumorsEwing Sarcoma Multimodal Protocol: Interval-Compressed VIDE Chemotherapy and Navigated Limb Preservation
Orthopaedic Oncology & Bone Tumors

Ewing Sarcoma Multimodal Protocol: Interval-Compressed VIDE Chemotherapy and Navigated Limb Preservation

11 min read
Sep 9, 2026
Spica Healthcare Clinical & Surgical Protocol Illustration #116

Clinical Summary & Key Takeaways

A pediatric and young adult orthopaedic oncology treatise on Ewing Sarcoma of bone and soft tissues, exploring the EWSR1-FLI1 genetic translocation, intensive neoadjuvant chemotherapy (VIDE / VDC-IE), computer-navigated wide resection, modular megaprosthesis reconstruction, and adjuvant radiation.

CRITICAL CLINICAL RED FLAG: A young child or teenager presenting with persistent, deep, localized bone pain (often worse at night) and a tender, warm, expanding soft tissue mass resembling osteomyelitis must undergo urgent plain radiography and contrast MRI before any surgical drainage is attempted.

1. Genetics & Pathophysiology: The EWSR1-ETS Fusion

Ewing Sarcoma is a highly malignant Small Round Blue Cell Tumor characterized in >85% of cases by the non-random reciprocal chromosomal translocation t(11;22)(q24;q12), generating the aberrant EWSR1-FLI1 chimeric oncoprotein. It predominantly affects children, adolescents, and young adults (ages 5 to 25) with a predilection for the diaphysis of long bones and the pelvis.

  • Onion-Skin Periosteal Reaction: Multi-layered subperiosteal new bone formation on plain radiographs.

  • Massive Soft Tissue Component: The extraosseous soft tissue mass is often significantly larger than the intraosseous bone lesion.

  • Mandatory Core Needle Biopsy: Verified by CD99 (MIC2) diffuse membranous positivity and EWSR1 rearrangement on FISH or RT-PCR.

2. Intensive Neoadjuvant Chemotherapy: The Euro-Ewing VIDE Regimen

Systemic chemotherapy is administered upfront to eradicate microscopic micrometastases and shrink the soft tissue mass:

  1. VIDE Protocol: 6 cycles of Vincristine, Ifosfamide (with Mesna uroprotection), Doxorubicin, and Etoposide administered every 21 days with G-CSF support.

  2. Interval-Compressed VDC/IE: Alternative regimen delivering Vincristine-Doxorubicin-Cyclophosphamide alternating with Ifosfamide-Etoposide every 14 days.

  3. Restaging MRI: Assesses volumetric tumor necrosis (>90% necrosis indicates excellent histological response).

"Integrating intensive interval-compressed multi-agent chemotherapy with precise 3D navigated surgical tumor clearance achieves 5-year survival rates exceeding 75% while preserving natural limbs in over 95% of cases." — Dr. Deepak Garg
Spica Healthcare Clinical & Surgical Protocol Illustration #116
Spica Healthcare Clinical & Surgical Protocol Illustration #116

3. Surgical Resection & Modular Megaprosthesis Reconstruction

Following neoadjuvant chemotherapy, wide en-bloc margin clearance is performed. For growing pediatric patients, custom modular expandable megaprostheses can be lengthened non-invasively using an external magnetic field without additional surgery.

CLINICAL CAUTION: Incision and drainage of a suspected Ewing Sarcoma misdiagnosed as an abscess contaminates anatomical tissue planes and drastically jeopardizes the chance of saving the limb.

4. Consolidation Radiotherapy & Maintenance

Adjuvant radiotherapy (45–54 Gy) is utilized for close surgical margins, pelvic primary sites, or poor histological responders to ensure long-term locoregional control.

5. Peer-Reviewed References & Clinical Guidelines

1. Results of the Euro-EWING99 trial: VIDE chemotherapy for localized and metastatic Ewing sarcoma — J Clin Oncol, 2020; 38(34): 3998-4007.

2. Limb-salvage surgery and reconstruction with modular prostheses in pediatric Ewing sarcoma — Bone Joint J, 2021; 103-B(9): 1560-1570.

Frequently Asked Patient Questions

Yes. Over 85% of modern systemic cancer protocols are delivered safely in dedicated outpatient daycare infusion suites with continuous electronic vitals monitoring, allowing patients to sleep in their own beds at home the same night.

Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.